Xencor, Inc Investing Cash Flow
Xencor, Inc (XNCR) reported Investing Cash Flow of $111.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-05
- Xencor, Inc net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $85.12M, a 110.30% increase year-over-year.
- Xencor, Inc net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $26.68M, a 95.18% increase year-over-year.
- Xencor, Inc net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $71.17M, a 24.32% increase year-over-year.
- Xencor, Inc net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $14.67M.
- Xencor, Inc net cash provided by (used in) investing activities for fiscal 2025 was $139.99M.
- Xencor, Inc net cash provided by (used in) investing activities for fiscal 2024 was -$7.87M.
- Xencor, Inc net cash provided by (used in) investing activities for fiscal 2023 was -$111.06M.
- Xencor, Inc net cash provided by (used in) investing activities for fiscal 2022 was -$119.72M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $85.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $111.80M 10-Q · filed 2026-08-05 | $182.97M derived: sum of 3 quarters · filed 2026-08-05 | $197.64M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | $26.68M 10-Q · filed 2026-05-06 | $97.85M derived: sum of 2 quarters · filed 2026-05-06 | $112.52M derived: sum of 3 quarters · filed 2026-05-06 | $152.99M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | $71.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $85.84M derived: sum of 2 quarters · filed 2026-02-25 | $126.32M derived: sum of 3 quarters · filed 2026-08-05 | $139.99M 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $14.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $55.14M derived: sum of 2 quarters · filed 2026-08-05 | $68.81M 10-Q · filed 2025-11-05 | $126.06M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | $40.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $54.14M 10-Q · filed 2026-08-05 | $111.40M derived: sum of 3 quarters · filed 2026-08-05 | -$52.06M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | $13.67M 10-Q · filed 2026-05-06 | $70.92M derived: sum of 2 quarters · filed 2026-05-06 | -$92.54M derived: sum of 3 quarters · filed 2026-05-06 | -$26.52M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $57.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$106.21M derived: sum of 2 quarters · filed 2026-02-25 | -$40.19M derived: sum of 3 quarters · filed 2026-02-25 | -$7.87M 10-K · filed 2026-02-25 | |||
| 2024-09-30 | -$163.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$97.44M derived: sum of 2 quarters · filed 2025-11-05 | -$65.12M 10-Q · filed 2025-11-05 | -$268.25M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-06-30 | $66.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $98.33M 10-Q · filed 2025-08-06 | -$104.80M derived: sum of 3 quarters · filed 2026-02-25 | -$59.47M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-03-31 | $32.32M 10-Q · filed 2025-05-07 | -$170.81M derived: sum of 2 quarters · filed 2026-02-25 | -$125.49M derived: sum of 3 quarters · filed 2026-02-25 | -$126.89M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2023-12-31 | -$203.13M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-25 | -$157.80M derived: sum of 2 quarters · filed 2026-02-25 | -$159.21M derived: sum of 3 quarters · filed 2026-02-25 | -$111.06M 10-K · filed 2026-02-25 | |||
| 2023-09-30 | $45.33M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-02-24 | $43.92M derived: sum of 2 quarters · filed 2025-02-24 | $92.06M 10-Q/A · filed 2025-02-24 | $116.61M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | -$1.41M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-02-24 | $46.74M 10-Q/A · filed 2025-02-24 | $71.29M derived: sum of 3 quarters · filed 2025-02-27 | $74.41M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | $48.14M 10-Q/A · filed 2025-02-24 | $72.69M derived: sum of 2 quarters · filed 2025-02-27 | $75.82M derived: sum of 3 quarters · filed 2025-02-27 | $178.00K derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $24.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $27.67M derived: sum of 2 quarters · filed 2025-02-27 | -$47.97M derived: sum of 3 quarters · filed 2025-02-27 | -$119.72M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$72.51M derived: sum of 2 quarters · filed 2023-11-08 | -$144.27M 10-Q · filed 2023-11-08 | -$136.41M derived: sum of 4 quarters · filed 2025-02-24 | |||
| 2022-06-30 | -$75.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$147.40M 10-Q · filed 2023-08-03 | -$139.54M derived: sum of 3 quarters · filed 2025-02-24 | -$178.39M derived: sum of 4 quarters · filed 2025-02-24 | |||
| 2022-03-31 | -$71.76M 10-Q · filed 2023-05-08 | -$63.90M derived: sum of 2 quarters · filed 2025-02-24 | -$102.75M derived: sum of 3 quarters · filed 2025-02-24 | -$156.06M derived: sum of 4 quarters · filed 2025-02-24 | |||
| 2021-12-31 | $7.86M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-02-24 | -$30.99M derived: sum of 2 quarters · filed 2025-02-24 | -$84.30M derived: sum of 3 quarters · filed 2025-02-24 | -$46.25M 10-K/A · filed 2025-02-24 | |||
| 2021-09-30 | -$38.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$92.16M derived: sum of 2 quarters · filed 2022-11-07 | -$54.11M 10-Q · filed 2022-11-07 | $24.67M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2021-06-30 | -$53.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$15.26M 10-Q · filed 2022-08-03 | $63.52M derived: sum of 3 quarters · filed 2023-02-27 | $12.96M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2021-03-31 | $38.05M 10-Q · filed 2022-05-05 | $116.83M derived: sum of 2 quarters · filed 2023-02-27 | $66.27M derived: sum of 3 quarters · filed 2023-02-27 | $125.67M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2020-12-31 | $78.78M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $28.22M derived: sum of 2 quarters · filed 2023-02-27 | $87.63M derived: sum of 3 quarters · filed 2023-02-27 | $100.19M 10-K · filed 2023-02-27 | |||
| 2020-09-30 | -$50.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $8.85M derived: sum of 2 quarters · filed 2021-11-08 | $21.41M 10-Q · filed 2021-11-08 | $37.14M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | $59.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $71.97M 10-Q · filed 2021-08-04 | $87.70M derived: sum of 3 quarters · filed 2022-02-24 | $109.76M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-03-31 | $12.56M 10-Q · filed 2021-05-05 | $28.29M derived: sum of 2 quarters · filed 2022-02-24 | $50.35M derived: sum of 3 quarters · filed 2022-02-24 | -$52.08M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | $15.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $37.79M derived: sum of 2 quarters · filed 2022-02-24 | -$64.64M derived: sum of 3 quarters · filed 2022-02-24 | -$50.97M 10-K · filed 2022-02-24 | |||
| 2019-09-30 | $22.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$80.37M derived: sum of 2 quarters · filed 2020-11-06 | -$66.70M 10-Q · filed 2020-11-06 | -$59.83M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-06-30 | -$102.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$88.76M 10-Q · filed 2020-08-05 | -$81.89M derived: sum of 3 quarters · filed 2021-02-24 | -$76.03M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-03-31 | $13.67M 10-Q · filed 2020-05-08 | $20.54M derived: sum of 2 quarters · filed 2021-02-24 | $26.40M derived: sum of 3 quarters · filed 2021-02-24 | -$163.77M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2018-12-31 | $6.87M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $12.73M derived: sum of 2 quarters · filed 2021-02-24 | -$177.44M derived: sum of 3 quarters · filed 2021-02-24 | -$164.77M 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $5.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$184.31M derived: sum of 2 quarters · filed 2019-11-05 | -$171.63M 10-Q · filed 2019-11-05 | -$162.69M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-06-30 | -$190.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$177.50M 10-Q · filed 2019-08-07 | -$168.56M derived: sum of 3 quarters · filed 2020-02-25 | -$163.62M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-03-31 | $12.67M 10-Q · filed 2019-05-09 | $21.61M derived: sum of 2 quarters · filed 2020-02-25 | $26.55M derived: sum of 3 quarters · filed 2020-02-25 | $35.98M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | $8.94M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $13.87M derived: sum of 2 quarters · filed 2020-02-25 | $23.31M derived: sum of 3 quarters · filed 2020-02-25 | $31.86M 10-K · filed 2020-02-25 | $31.95M 10-K · filed 2018-02-28 | ||
| 2017-09-30 | $4.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $14.37M derived: sum of 2 quarters · filed 2018-11-05 | $22.93M 10-Q · filed 2018-11-05 | $23.01M 10-Q · filed 2017-11-08 | -$81.97M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-06-30 | $9.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $17.99M 10-Q · filed 2018-08-07 | $18.08M 10-Q · filed 2017-08-07 | -$86.90M derived: sum of 3 quarters · filed 2019-02-26 | -$214.56M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-03-31 | $8.55M 10-Q · filed 2018-05-07 | -$96.34M derived: sum of 2 quarters · filed 2019-02-26 | -$224.00M derived: sum of 3 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | -$104.89M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$232.56M derived: sum of 2 quarters · filed 2019-02-26 | -$214.27M 10-K · filed 2019-02-26 | -$213.65M 10-K · filed 2018-02-28 | |||
| 2016-09-30 | -$127.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$109.38M 10-Q · filed 2017-11-08 | |||||
| 2016-06-30 | $18.28M 10-Q · filed 2017-08-07 | ||||||
| 2015-12-31 | -$185.11M 10-K · filed 2018-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |